JP2023521662A5 - - Google Patents
Info
- Publication number
- JP2023521662A5 JP2023521662A5 JP2022560207A JP2022560207A JP2023521662A5 JP 2023521662 A5 JP2023521662 A5 JP 2023521662A5 JP 2022560207 A JP2022560207 A JP 2022560207A JP 2022560207 A JP2022560207 A JP 2022560207A JP 2023521662 A5 JP2023521662 A5 JP 2023521662A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- nucleic acid
- epitope
- coding nucleic
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063005160P | 2020-04-03 | 2020-04-03 | |
| US63/005,160 | 2020-04-03 | ||
| PCT/US2021/025828 WO2021203104A1 (en) | 2020-04-03 | 2021-04-05 | Infectious disease antigens and vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023521662A JP2023521662A (ja) | 2023-05-25 |
| JP2023521662A5 true JP2023521662A5 (https=) | 2024-04-17 |
Family
ID=77929685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022560207A Pending JP2023521662A (ja) | 2020-04-03 | 2021-04-05 | 感染症抗原及びワクチン |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4125944A4 (https=) |
| JP (1) | JP2023521662A (https=) |
| KR (1) | KR20230006825A (https=) |
| CN (1) | CN115942942A (https=) |
| AU (1) | AU2021247302A1 (https=) |
| CA (1) | CA3173793A1 (https=) |
| IL (1) | IL296752A (https=) |
| WO (1) | WO2021203104A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4419708A1 (en) * | 2021-10-18 | 2024-08-28 | BioNTech SE | Methods for determining mutations for increasing modified replicable rna function and related compositions and their use |
| WO2024077299A2 (en) * | 2022-10-07 | 2024-04-11 | The Trustees Of Indiana University | Recombinant rotaviruses and methods and systems for producing the same |
| CN120641124A (zh) * | 2022-10-21 | 2025-09-12 | Pds生物科技公司 | 用对映特异性阳离子脂质r-dotap配制的重组蛋白疫苗及其使用方法 |
| CN116218889A (zh) * | 2022-12-13 | 2023-06-06 | 浙江大学 | 一种表达猫细小病毒VP2蛋白的mRNA疫苗及其制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6770283B1 (en) * | 1990-12-13 | 2004-08-03 | Bioption Ab | DNA expression systems based on alphaviruses |
| US6015686A (en) * | 1993-09-15 | 2000-01-18 | Chiron Viagene, Inc. | Eukaryotic layered vector initiation systems |
| DE602005017743D1 (de) * | 2004-01-23 | 2009-12-31 | Angeletti P Ist Richerche Bio | Impfstoffträger für schimpansen-adenovirus |
| CA2766907A1 (en) * | 2009-07-06 | 2011-01-13 | Novartis Ag | Self replicating rna molecules and uses thereof |
| EP3250233A4 (en) * | 2015-01-29 | 2018-07-25 | Agency for Science, Technology and Research | Nanocapsules carrying chikungunya-associated peptides |
| EP4011451A1 (en) * | 2015-10-22 | 2022-06-15 | ModernaTX, Inc. | Metapneumovirus mrna vaccines |
| BR112018014109A2 (en) * | 2016-01-11 | 2018-12-11 | Verndari, Inc. | microneedle compositions and methods of using them |
| EP3634449A4 (en) * | 2017-05-08 | 2021-03-17 | Gritstone Oncology, Inc. | ALPHAVIRUS NEOANTIGEN VECTORS |
| US12083174B2 (en) * | 2018-08-17 | 2024-09-10 | Glaxosmithkline Biologicals Sa | Immunogenic compositions and uses thereof |
| KR20230120646A (ko) * | 2020-12-02 | 2023-08-17 | 세퀴러스 인코포레이티드 | 멀티시스트론성 rna 백신 및 이의 용도 |
-
2021
- 2021-04-05 IL IL296752A patent/IL296752A/en unknown
- 2021-04-05 WO PCT/US2021/025828 patent/WO2021203104A1/en not_active Ceased
- 2021-04-05 CA CA3173793A patent/CA3173793A1/en active Pending
- 2021-04-05 KR KR1020227038618A patent/KR20230006825A/ko active Pending
- 2021-04-05 AU AU2021247302A patent/AU2021247302A1/en active Pending
- 2021-04-05 JP JP2022560207A patent/JP2023521662A/ja active Pending
- 2021-04-05 EP EP21780767.6A patent/EP4125944A4/en active Pending
- 2021-04-05 CN CN202180040267.1A patent/CN115942942A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023526495A5 (https=) | ||
| JP2021525076A5 (https=) | ||
| JP2023521662A5 (https=) | ||
| JP2023541108A5 (https=) | ||
| JP2022512912A5 (https=) | ||
| JP2022539417A5 (https=) | ||
| JP2021524247A5 (https=) | ||
| CA3030451C (en) | Compositions and methods for alphavirus vaccination | |
| US20230270841A1 (en) | Coronavirus vaccine | |
| JP2022534282A5 (https=) | ||
| RU2019119272A (ru) | Вирусная доставка неоантигенов | |
| JP2023523413A5 (https=) | ||
| JP2018536433A5 (https=) | ||
| Lundstrom | Alphavirus vectors for vaccine production and gene therapy | |
| JP2023523414A5 (https=) | ||
| AU2017372731A1 (en) | Compositions and methods for enhancing gene expression | |
| JPH09511143A (ja) | アルファーウイルスｃＤＮＡベクター | |
| JP2022512912A (ja) | アルファウイルス新生抗原ベクター及びインターフェロン阻害因子 | |
| CN114854773A (zh) | 顺式复制子构建体 | |
| TWI769467B (zh) | 用作b型肝炎病毒(hbv)疫苗之自我複製rna分子及其用途 | |
| JP2023509966A5 (https=) | ||
| JPWO2012053646A1 (ja) | ワクシニアウイルスベクターおよびセンダイウイルスベクターからなるプライム／ブーストワクチン用ウイルスベクター | |
| WO2008119827A1 (en) | Transreplicase constructs | |
| CN106459998A (zh) | 预防或治疗慢性乙型肝炎病毒(hbv)感染的基于病毒样囊泡(vlv)的疫苗 | |
| CA3188801A1 (en) | Rna replicon vaccines against hbv |